Page 3 of Sun Pharma

Sun Pharma, novel therapy, skin disorders, skin disorders in India, Sun Pharma news, healthcare news, pharma news,

Sun Pharma gets regulatory nod in Australia for acne treatment cream

The approval is for Winlevi (clascoterone cream 1 per cent), which is indicated for the topical treatment of acne vulgaris…

Updated: March 19, 2024 11:16 IST

Sun Pharma, Bayer, Bayer pharma, cardiac care, heart patients, healthcare news, pharma news,

Bayer and Sun Pharma sign marketing and distribution agreement for second brand of cardiac drug in India

The Indian Chronic Kidney Disease (ICKD) study identifies diabetes as the leading cause of chronic kidney disease and end-stage kidney…

January 18, 2024 15:18 IST

Sun Pharma, Taro, acquisition, shares, investment, merger, generic dermatology market

Sun Pharma to acquire remaining 21.52% shares of Taro for Rs 2,891.76 crore

Dilip Shanghvi, Managing Director of Sun Pharma, said, “Post completion of the merger, the combined entity will firmly move forward,…

January 18, 2024 13:47 IST

Dilip Sanghvi, Dilip Sanghvi net worth, Dilip Sanghvi lifestyle, Dilip Sanghvi forbes, who is Dilip Sanghvi, Sun Pharma, Dilip Sanghvi Sun Pharma, lifestyle

Who is Indian billionaire Dilip Sanghvi, the man behind Sun Pharma? Know about his Rs 15.65 lakh crore net worth

Founder of Sun Pharma, Shanghvi commands a business empire generating $5.4 billion (approximately Rs 44,971 crore) in revenue.

Updated: December 21, 2023 00:37 IST

Sun Pharma inks licensing pact with Aclaris Therapeutics for autoimmune disorder drug

The agreement has been signed between Sun Pharmaceutical Industries, Inc. Aclaris Therapeutics.

December 6, 2023 13:35 IST

Sun Pharma’s shares advance on Q2 results; Should you buy, hold or sell the stock?

Sun Pharma’s share price gained 1.48% in the last five days, while it dropped 1.13% in the last one month.…

Updated: November 2, 2023 11:28 IST

Sun Pharma Q2 Results: Profit rises 5% to Rs 2375.51 crore, beats estimates

Sun Pharma posted revenue from operations at Rs 12,192.41 crore, up 11.3 per cent as against Rs 10,952.28 crore during…

November 1, 2023 15:49 IST

Divi's Laboratories, Pharmaceutical, pharma industry, Q2FY24 results, profit, revenue, EBITDA

Sun Pharma and Zydus sign licensing agreement to co-market critical drug for Chronic Kidney Disease patients in India

Under the terms of this agreement, Zydus has granted Sun Pharma semi-exclusive rights to co-market the product in India.

October 30, 2023 13:23 IST

Sun Pharma, Philogen, Melanoma, Skin cancer, healthcare news, pharma news,

Sun Pharma and Philogen’s melanoma drug shows promising outcome in Phase 3 trial

On May 30, 2023, Philogen and Sun Pharma entered into a distribution, license, and supply agreement for commercializing Nidlegy in…

October 16, 2023 17:20 IST

Sun Pharma, Eye diseases, Eye disorder, dry eyes, trial results, healthcare news, pharma news,

Sun Pharma’s eye drug shows promising results in Phase 4 trial

CEQUA was generally well tolerated in the study, consistent with its established safety profile, and there were no new safety…

October 13, 2023 12:25 IST

Sun Pharma launches novel topical treatment for acne in Canada

WINLEVI is the first and only topical androgen receptor inhibitor, and the newest Health Canada-approved formulation to target the hormonal…

September 27, 2023 14:28 IST

Generic medicines, biosimilars, Cipla, Sun Pharma, healthcare news, pharma news,

Generic and biosimilar products are still out of reach for many patients in LMICs, reveals new report

Of the medicines classed as “essential” by the World Health Organization (WHO), 90 percent are off patent, including treatments for…

September 26, 2023 15:06 IST

Sun Pharma posts Q1 profit at Rs 2022.54 cr on low profitability at Taro; MD says well positioned to meet FY24 guidance

Sun Pharmaceutical posted revenue from operations at Rs 11,940.84 crore, up 11 per cent as against Rs 10,761.76 crore during…

August 4, 2023 11:41 IST

Sun Pharma and Philogen enter into exclusive agreement for commercialising skin cancer drug in Europe, Australia and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers…

May 31, 2023 11:13 IST

Sun Pharma proposes to fully acquire Israel-based Taro Pharmaceutical Industries

Sun Pharmaceutical Industries on Saturday said it has proposed to fully acquire Israel-based Taro Pharmaceutical Industries through a reverse triangular…

May 27, 2023 17:50 IST

Sun Pharma, fourth quarter, Q4FY23 results, profit, revenue, dividend

Sun Pharma posts Q4FY23 profit at Rs 1,984.47 crore, revenue up 15.7% on-year; dividend declared

Sun Pharma posted revenue from operations at Rs 10,930.67 crore, up 15.7 per cent as against Rs 9,446.76 crore in…

May 26, 2023 15:27 IST

Dilip Shanghvi net worth, who is dilip shanghvi, dilip shanghvi journey,, Sun Pharmaceutical Industries Limited, entrepreneur, healthcare industry, affordable medicines, generic and branded pharmaceutical products, business family, net worth, low-key lifestyle, philanthropy, sun foundation.

Meet Padma Shri Dilip Shanghvi, a visionary who transformed Indian healthcare industry: Know about his journey, education, net worth and more

In this article, we will take a look at Shanghvi’s journey, family, education, net worth and more.

April 29, 2023 09:00 IST

Sun Pharma launches novel therapy for Dry Eye Disease in India

The prevalence of DED in India is higher than the global prevalence and a large regional study pegged India’s prevalence…

April 25, 2023 15:48 IST

Related News

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

Employee quits google job, Google Manager Quits Rs 3.4 Crore Job

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Tata Capital IPO updates 2025, Tata Capital IPO live allotment status

LIVE: Tata Capital IPO allotment to be finalised today, GMP nears issue price – Step by step guide to check status online

Engineer denied B2 visa despite stable job and business, officer says ‘unfortunately you are…’

INDIA bloc mulls three Dy CMs, Tejashwi Yadav likely CM face

India News37 min ago

The INDIA bloc is likely to name RJD leader Tejashwi Yadav as the CM’s face for the Bihar election and appoint three deputy CMs from various groups – one Muslim, Dalit and extremely backward classes. The seat-sharing formula is almost finalised, with RJD contesting on 130 seats. This decision has been praised by alliance members for promoting inclusivity.

View all shorts